Vaccine trial: Negotiations underway between BSMMU, Sanofi
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
February 07, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, FEBRUARY 07, 2023
Vaccine trial: Negotiations underway between BSMMU, Sanofi

Covid-19 in Bangladesh

TBS Report
21 November, 2020, 10:45 pm
Last modified: 22 November, 2020, 10:58 am

Related News

  • UNFPA and BRAC host knowledge dissemination event on Covid-19
  • The supply chain crisis opens door to resilience
  • Hong Kong says 'hello' to woo back visitors after Covid
  • US to end Covid-19 emergency declarations on 11 May
  • Rally, scientific seminar to prevent cervical cancer held at Labaid Hospital

Vaccine trial: Negotiations underway between BSMMU, Sanofi

BSMMU sources said 500 volunteers will participate in the proposed human trial

TBS Report
21 November, 2020, 10:45 pm
Last modified: 22 November, 2020, 10:58 am
Representational Image. Photo: Reuters
Representational Image. Photo: Reuters

The Bangabandhu Sheikh Mujib Medical University Hospital (BSMMU) is negotiating the terms and conditions of human trial for a Covid-19 vaccine with French multinational pharmaceutical company Sanofi.

Confirming the matter, BSMMU Vice-Chancellor Professor Kanak Kanti Barua told The Business Standardsaid, "Discussions are underway with Sanofi, and we will make an agreement with them after the process is complete."

"The BSMMU has already applied to the Bangladesh Medical Research Council (BMRC) for permission to carry out the vaccine trial," he added.

BMRC's Director Dr Mahmood-Uz-Zahan, however, declined to make any comments on the matter.

According to BSMMU sources, 500 volunteers will participate in the proposed human trial.

According to the World Health Organisation's draft list of vaccine candidates, Sanofi is developing two Covid-19 vaccines – one is currently in the clinical trial stage, and the other is in pre-clinical stage. Sanofi is now conducting their phase-1 and phase-2 clinical trials in the USA.

The Bangladesh government on 27 August gave approval to the Chinese biopharmaceutical company Sinovac for a human trial of their Covid-19 vaccine.

The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) was supposed to conduct the human trial on 4,200 healthcare workers at seven dedicated Covid-19 hospitals in Dhaka.

But the initiative was put on hold after the company demanded co-funding from the Bangladesh government for the human trial.

Top News

COVID-19 / Vaccine / BSMMU / Sanofi

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • A man stands in front of collapsed buildings following an earthquake in Kahramanmaras, Turkey February 6, 2023. Ihlas News Agency (IHA) via REUTERS ATTENTION EDITORS - THIS PICTURE WAS PROVIDED BY A THIRD PARTY. NO RESALES. NO ARCHIVES. TURKEY OUT. NO COMMERCIAL OR EDITORIAL SALES IN TURKEY.
    Deaths exceed 2,600 as catastrophic quakes ravage Turkey, Syria
  • 30% cos see double-digit growth even in hard times
    30% cos see double-digit growth even in hard times
  • Govt borrowing from commercial banks surges
    Govt borrowing from commercial banks surges

MOST VIEWED

  • Incepta Pharma abandons Covid vaccine plan
    Incepta Pharma abandons Covid vaccine plan
  • Test tube labelled "Covid-19 Omicron variant test positive" is seen in this illustration picture taken 15 January, 2022. PHOTO: REUTERS/Dado Ruvic/Illustration
    Tighter screening at ports urged as new Covid sub-variant BF.7 detected
  • Test tube labelled "Covid-19 Omicron variant test positive" is seen in this illustration picture taken 15 January, 2022. PHOTO: REUTERS/Dado Ruvic/Illustration
    First case of new Covid sub-variant Omicron BF.7 detected in Bangladesh: IEDCR
  • Illustration: Collected
    Genome sequencing reports of Chinese nationals infected with Covid by Sunday: IEDCR
  • Computer image of a betacoronavirus which is the type of virus linked to Covid-19
    4 Chinese nationals detected with Covid at Dhaka airport
  • Omicron BF7: Land ports still left unguarded
    Omicron BF7: Land ports still left unguarded

Related News

  • UNFPA and BRAC host knowledge dissemination event on Covid-19
  • The supply chain crisis opens door to resilience
  • Hong Kong says 'hello' to woo back visitors after Covid
  • US to end Covid-19 emergency declarations on 11 May
  • Rally, scientific seminar to prevent cervical cancer held at Labaid Hospital

Features

Photo: Collected

Get your partner a lovely present this Valentine's Day

14h | Brands
Pottery Wheel Craft Kit: A creative outlet for little hands

Pottery Wheel Craft Kit: A creative outlet for little hands

13h | Brands
Say it with Colours

Say it with Colours

1d | Mode
Photo: Courtesy

From 'Made in Bangladesh' to 'Designed in Bangladesh'

1d | Panorama

More Videos from TBS

Who will survive? Adani or Hindenburg?

Who will survive? Adani or Hindenburg?

5h | TBS Stories
James Gunn’s 8-10-year plan for the DC Universe

James Gunn’s 8-10-year plan for the DC Universe

5h | TBS Entertainment
LC issues lead to severe shortage of surgical equipment

LC issues lead to severe shortage of surgical equipment

8h | TBS Insight
Stage plays are going on in the digital age

Stage plays are going on in the digital age

13h | TBS Stories

Most Read

1
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

2
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

3
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

4
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

5
Photo: Collected
Startups

ShopUp secures $30m debt financing to boost expansion, supply chain

6
Photo: Courtesy
Panorama

From 'Made in Bangladesh' to 'Designed in Bangladesh'

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]